Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimizing Linezolid Dosing in Advanced Renal Impairment
NCT07138521Phase 4Not yet recruiting
- Sponsor
- Alexandria University
- Start
- Oct 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of linezolid in bacterial infection (3 arms), sponsored by Alexandria University. Primary endpoint: Therapeutic range trough targeting. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
linezolid
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT07138521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07138521.